Singer DE - Search Results

1

Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial.

Singer DE, Hellkamp AS, Yuan Z, Lokhnygina Y, Patel MR, Piccini JP, Hankey GJ, Breithardt G, Halperin JL, Becker RC, Hacke W, Nessel CC, Mahaffey KW, Fox KA, Califf RM; ROCKET AF Investigators. Singer DE, et al. J Am Heart Assoc. 2015 Mar 3;4(3):e001349. doi: 10.1161/JAHA.114.001349. J Am Heart Assoc. 2015. PMID: 25736441 Free PMC article. Clinical Trial.

2

The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study.

Singer DE, Hughes RA, Gress DR, Sheehan MA, Oertel LB, Maraventano SW, Blewett DR, Rosner B, Kistler JP. Singer DE, et al. Am Heart J. 1992 Dec;124(6):1567-73. doi: 10.1016/0002-8703(92)90074-6. Am Heart J. 1992. PMID: 1462916 Clinical Trial.

3

The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.

Lancaster TR, Singer DE, Sheehan MA, Oertel LB, Maraventano SW, Hughes RA, Kistler JP. Lancaster TR, et al. Among authors: singer de. Arch Intern Med. 1991 Oct;151(10):1944-9. Arch Intern Med. 1991. PMID: 1929681 Clinical Trial.

4

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

Hylek EM, Skates SJ, Sheehan MA, Singer DE. Hylek EM, et al. Among authors: singer de. N Engl J Med. 1996 Aug 22;335(8):540-6. doi: 10.1056/NEJM199608223350802. N Engl J Med. 1996. PMID: 8678931 Free article.

5

Anticoagulation for atrial fibrillation: epidemiology informing a difficult clinical decision.

Singer DE. Singer DE. Proc Assoc Am Physicians. 1996 Jan;108(1):29-36. Proc Assoc Am Physicians. 1996. PMID: 8834062 Review.

6

Determinants of compliance with anticoagulation: A case-control study.

Arnsten JH, Gelfand JM, Singer DE. Arnsten JH, et al. Among authors: singer de. Am J Med. 1997 Jul;103(1):11-7. doi: 10.1016/s0002-9343(97)90048-6. Am J Med. 1997. PMID: 9236480

7

Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE. Hylek EM, et al. Among authors: singer de. Arch Intern Med. 2000 Jun 12;160(11):1612-7. doi: 10.1001/archinte.160.11.1612. Arch Intern Med. 2000. PMID: 10847254

8

Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.

Hylek EM, Regan S, Go AS, Hughes RA, Singer DE, Skates SJ. Hylek EM, et al. Among authors: singer de. Ann Intern Med. 2001 Sep 18;135(6):393-400. doi: 10.7326/0003-4819-135-6-200109180-00008. Ann Intern Med. 2001. PMID: 11560452

9

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.

Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE. Hylek EM, et al. Among authors: singer de. N Engl J Med. 2003 Sep 11;349(11):1019-26. doi: 10.1056/NEJMoa022913. N Engl J Med. 2003. PMID: 12968085 Free article.

10

The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage.

Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. Rosand J, et al. Among authors: singer de. Arch Intern Med. 2004 Apr 26;164(8):880-4. doi: 10.1001/archinte.164.8.880. Arch Intern Med. 2004. PMID: 15111374

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

448 results

Search Page